Quality Measures in Heart Failure: the Past, the Present, and the Future

被引:5
|
作者
Polanczyk C.A. [1 ,2 ,3 ]
Ruschel K.B. [1 ,2 ]
Castilho F.M. [1 ,4 ]
Ribeiro A.L. [1 ,4 ]
机构
[1] National Institute of Science and Technology for Health Technology Assessment (IATS), CNPq, 2350 Ramiro Barcelos, room 21507, Porto Alegre, 90035-903, RS
[2] Graduate Program in Cardiology and Cardiovascular Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre
[3] Cardiology Center, Hospital Moinhos de Vento, Porto Alegre
[4] Hospital das Clínicas and School of Medicine, Universidade Federal Minas Gerais, Belo Horizonte
关键词
Big data; Health indicators; Heart failure; Outcome; Quality of care; Readmission;
D O I
10.1007/s11897-019-0417-0
中图分类号
学科分类号
摘要
Purpose of Review: This paper reviews performance measure in health, their importance, and methodologic issues, focusing on metrics for health failure patients. Quality measures are instruments to assess structural aspects or processes of care aiming to guarantee that optimal patient outcomes are achieved. As heart failure is a chronic condition in which established therapies reduce mortality and hospital admissions, there are quite a lot of initiatives that aim to monitor for quality of care and to coordinate the disease management. Recent Findings: Several performance measures were validated for these patients, from process of care (left ventricular function assessment and use of ACEi/ARBs and beta-blockers) to health outcomes (hospital mortality and readmissions). In the early years, studies demonstrated a relationship between quality measurements and health outcomes. Nonetheless, more recent ones based on large databases of patients’ medical records have shown that traditional indicators explain only a small fraction of health and patient reported- and perceived outcomes. Public reporting of quality measures and payment conditioned to the quality of care provided were not able to show benefit in terms of hard outcomes. Data science and big data methods are promising in providing actionable knowledge for quality improvement, with real-time data that could support decision-making. Summary: Heart failure is a chronic condition that has proven to be useful for measuring medical and healthcare quality. Evidence-based indicators have already reached high rates of adherence and are currently poorly correlated with outcomes. Using real-life data and based on the patient’s perspective can be useful tools to improve these indicators. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:1 / 6
页数:5
相关论文
共 50 条
  • [1] Heart failure pharmacogenetics: Past, present, and future
    Davis H.M.
    Johnson J.A.
    [J]. Current Cardiology Reports, 2011, 13 (3) : 175 - 184
  • [2] The Management of Heart Failure The Past, the Present, and the Future
    Braunwald, Eugene
    [J]. CIRCULATION-HEART FAILURE, 2008, 1 (01) : 58 - 62
  • [3] The past, present and future of heart failure therapies
    Leslie, S. J.
    [J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2006, 36 (03): : 249 - 252
  • [4] Levosimendan in acute heart failure: Past, present and future
    Delgado, Juan F.
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (04): : 309 - 312
  • [5] Heart failure nursing in Australia: Past, present and future
    Davidson, Patricia M.
    Stewart, Simon
    [J]. AUSTRALIAN CRITICAL CARE, 2009, 22 (03) : 108 - 110
  • [6] Biomarkers of Heart Failure: Past, Present, and Future Preface
    Suzuki, Toru
    Bossone, Eduardo
    [J]. HEART FAILURE CLINICS, 2018, 14 (01) : IX - X
  • [7] Understanding the Epidemic of Heart Failure: Past, Present, and Future
    Dunlay S.M.
    Roger V.L.
    [J]. Current Heart Failure Reports, 2014, 11 (4) : 404 - 415
  • [8] Carvedilol in chronic heart failure: past, present and future
    Weir, Robin A. P.
    Dargie, Henry J.
    [J]. FUTURE CARDIOLOGY, 2005, 1 (06) : 723 - 734
  • [9] Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future
    Zhou, Shujing
    Liu, Ying
    Huang, Xufeng
    Wu, Chuhan
    Porszasz, Robert
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [10] The past, the present, and the future of natriuretic peptides in the diagnosis of heart failure
    Gaggin, Hanna K.
    Januzzi, James L., Jr.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2018, 20 (0G) : G11 - G20